Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011;32(1):26-31.
doi: 10.1159/000330343. Epub 2011 Aug 5.

Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease

A Klimkowicz-Mrowiec  1 , M Marona, K Spisak, J Jagiella, P Wolkow, A Szczudlik, A Slowik
Affiliations

Paraoxonase 1 gene polymorphisms do not influence the response to treatment in Alzheimer's disease

A Klimkowicz-Mrowiec et al. Dement Geriatr Cogn Disord. 2011.

Abstract

Background: Acetylcholinesterase inhibitors (AChEIs) are the treatment of choice for patients with Alzheimer's disease (AD). However, their efficacy is moderate and differs from patient to patient. Recent studies suggest that the Q192R variant of the paraoxonase 1 gene (PON1) might affect individual susceptibility to these drugs.

Methods: We investigated the influence of 3 single nucleotide polymorphisms (SNPs) in PON1 (rs 662, rs 854560, rs 705381) and the APOE common polymorphism in 101 Polish patients with late-onset AD in response to treatment with AChEIs.

Results: No significant differences were observed between carriers and non-carriers of the PON1 SNPs or the APOE common polymorphism in terms of treatment response. These results did not change after stratification of APOE status.

Conclusion: Our results suggest that both the investigated PON1 and APOE common SNPs do not influence treatment response to AChEIs in patients with AD.

PubMed Disclaimer

MeSH terms

LinkOut - more resources